A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO)
Powles, T Larkin, JMG Patel, P Perez-Valderrama, B Rodriguez-Vida, A Glen, H Thistlethwaite, Fiona C Ralph, Christy Srinivasan, G Mendez-Vidal, MJ
Powles, T
Larkin, JMG
Patel, P
Perez-Valderrama, B
Rodriguez-Vida, A
Glen, H
Thistlethwaite, Fiona C
Ralph, Christy
Srinivasan, G
Mendez-Vidal, MJ
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Powles T, Larkin JMG, Patel P, P�rez-Valderrama B, Rodriguez-Vida A, Glen H, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). J Clin Oncol. 2019;37(7_suppl):545-.